These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31628728)

  • 21. Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure.
    Millington-Burgess SL; Harper MT
    Sci Rep; 2021 Sep; 11(1):17678. PubMed ID: 34480042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of platelets from blood plasma to improve the quality of extracellular vesicle research.
    Bettin B; Gasecka A; Li B; Dhondt B; Hendrix A; Nieuwland R; van der Pol E
    J Thromb Haemost; 2022 Nov; 20(11):2679-2685. PubMed ID: 36043239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.
    Chennakrishnaiah S; Meehan B; D'Asti E; Montermini L; Lee TH; Karatzas N; Buchanan M; Tawil N; Choi D; Divangahi M; Basik M; Rak J
    J Thromb Haemost; 2018 Sep; 16(9):1800-1813. PubMed ID: 29971917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets.
    Yu Y; Gool E; Berckmans RJ; Coumans FAW; Barendrecht AD; Maas C; van der Wel NN; Altevogt P; Sturk A; Nieuwland R
    J Thromb Haemost; 2018 Jun; 16(6):1153-1163. PubMed ID: 29658195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The procoagulant effects of extracellular vesicles derived from hypoxic endothelial cells can be selectively inhibited by inorganic nitrite.
    Whelan C; Burnley-Hall N; Morris K; Rees DA; James PE
    Nitric Oxide; 2022 May; 122-123():6-18. PubMed ID: 35202833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitive tissue factor activity assay determined by an optimized thrombin generation method.
    Kristensen SR; Nybo J
    PLoS One; 2023; 18(7):e0288918. PubMed ID: 37467256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Comparison of Two Neonatal ECMO Circuits Using a Roller or Centrifugal Pump With Three Different In-Line Hemoconcentrators for Maintaining Hemodynamic Energy Delivery to the Patient.
    Force M; Moroi M; Wang S; Palanzo DA; Kunselman AR; Ündar A
    Artif Organs; 2018 Apr; 42(4):354-364. PubMed ID: 29323409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sources of Circuit Thrombosis in Pediatric Extracorporeal Membrane Oxygenation.
    Hastings SM; Ku DN; Wagoner S; Maher KO; Deshpande S
    ASAIO J; 2017; 63(1):86-92. PubMed ID: 27660905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
    Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
    Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet Adhesion and Activation in an ECMO Thrombosis-on-a-Chip Model.
    Goh T; Gao L; Singh J; Totaro R; Carey R; Yang K; Cartwright B; Dennis M; Ju LA; Waterhouse A
    Adv Sci (Weinh); 2024 Aug; 11(30):e2401524. PubMed ID: 38757670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Not just small adults: Considering the impact of developmental hemostasis on neonatal extracorporeal circulation.
    Guzzetta NA; Downey LA
    J Thromb Haemost; 2020 Jun; 18(6):1509-1510. PubMed ID: 32496015
    [No Abstract]   [Full Text] [Related]  

  • 32. Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits.
    Young G; Yonekawa KE; Nakagawa P; Nugent DJ
    Perfusion; 2004; 19(5):283-8. PubMed ID: 15506032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Expression of Extracellular Vesicles Is Associated With the Procoagulant State in Patients With Established Rheumatoid Arthritis.
    Stojanovic A; Veselinovic M; Zong Y; Jakovljevic V; Pruner I; Antovic A
    Front Immunol; 2021; 12():718845. PubMed ID: 34394126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
    Rothmeier AS; Versteeg HH; Ruf W
    J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of thromboelastography in children on extracorporeal membrane oxygenation.
    Wagner ML; Johnston M; Jenkins T; Palumbo JS; Rymeski BA
    J Pediatr Surg; 2022 Jun; 57(6):1056-1061. PubMed ID: 35304022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel.
    Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Lacroix R; Leroyer A; Opolski G; Pluta K; van der Pol E; Postuła M; Siljander P; Siller-Matula JM; Filipiak KJ
    J Thromb Haemost; 2020 Mar; 18(3):609-623. PubMed ID: 31833175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling.
    Buntsma NC; Gąsecka A; Roos YBWEM; van Leeuwen TG; van der Pol E; Nieuwland R
    Platelets; 2022 Jul; 33(5):764-771. PubMed ID: 34697987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study.
    Wannez A; Devalet B; Bouvy C; Laloy J; Bihin B; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Res; 2017 Aug; 156():142-148. PubMed ID: 28646725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Interaction of Platelet-Derived Extracellular Vesicles With Circulating Immune Cells: Roles of TAM Receptors, CD11b, and Phosphatidylserine.
    Fendl B; Eichhorn T; Weiss R; Tripisciano C; Spittler A; Fischer MB; Weber V
    Front Immunol; 2018; 9():2797. PubMed ID: 30619243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.